— Know what they know.
Not Investment Advice

UPB NASDAQ

Upstream Bio, Inc.
1W: -3.8% 1M: -12.2% 3M: +4.7% YTD: -67.6% 1Y: +11.6%
$8.37
-0.09 (-1.06%)
 
Weekly Expected Move ±7.0%
$8 $8 $9 $10 $10
NASDAQ · Healthcare · Biotechnology · Alpha Radar Sell · Power 31 · $455.5M mcap · 20M float · 3.99% daily turnover · Short 30% of daily vol

Cash Flow Trends

Operating Cash Flow
-$133M -125.2% ▼
Capital Expenditures
$165K +67.7% ▲
3Y CAGR: +26.2%
Free Cash Flow
-$133M -123.3% ▼
Dividends Paid
$0 +0.0% ▲
Buybacks
$0 +0.0% ▲
Net Change in Cash
-$224M -174.7% ▼

Cash Flow Composition

Year-over-Year Growth

View Full Cash Flow Statement
Line ItemFY2022FY2023FY2024FY2025
— Operating Activities —
Net Income-$24M-$21M-$63M-$143M
Depreciation & Amort.$7K$60K$89K-$1M
Stock-Based Comp.$1M$3M$6M$10M
Change in Working Capital$3M-$4M$2M$589K
Other Non-Cash Items$149K-$17M-$4M$561K
Operating Cash Flow-$19M-$38M-$59M-$133M
— Investing Activities —
Capital Expenditures-$82K-$144K-$511K-$165K
Acquisitions (Net)$0$0$0$0
Investment Purchases$0-$129M-$291M-$386M
Investment Sales$0$46M$232M$293M
Other Investing$0$0$0$0
Investing Cash Flow-$82K-$83M-$59M-$93M
— Financing Activities —
Net Debt Issuance$0$0$0$0
Stock Repurchased$0$0$0$0
Dividends Paid$0$0$0$0
Other Financing-$37K$118K-$4M$0
Financing Cash Flow$10M$130M$419M$2M
Net Change in Cash-$9M$9M$300M-$224M
Cash End of Period$17M$26M$326M$102M
Free Cash Flow-$19M-$38M-$60M-$133M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms